MAPK3 and breast carcinoma: And previous studies have shown that steroidal estrogens are able to rapidly and transiently activate the ERK1/2 pathway [13], so we examined whether the ERK1/2 pathway was involved in the effect of E2 on HBO1 expression in breast cancer cells.